UCSF study finds that changes in daily salt intake may explain eczema flares.
Cardiovascular startup raises $260 million led by ex-Moderna execs’ new VC fund
Cardurion Pharmaceuticals, a startup that launched seven years ago with shelved cardiovascular drug candidates from Takeda Pharmaceuticals, has raised $260 million for a Series B